Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: Clues to pathogenesis

International Journal of Gynecological Pathology

Volumn 18, Issue 3, 1999, Pages 233-237

  Demopoulos, Rita Iovine ^a,c   Mesia, Augusto F ^a   Mittal, Khush ^a   Vamvakas, Eleftherios ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Carcinoma; Endometrioid; Immunohistochemistry; Papillary; Serous; Uterine

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; UVOMORULIN;

ANIMAL TISSUE; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CELL ADHESION; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0033054329     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199907000-00008     Document Type: Article

References (15)

1. Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinomas: two clinicopathological types. Int J Gynecol Pathol 1985;4:279-88.
2. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
3. Sutton GP, Brill L, Michael H. Stehman FB, Ehrlich CE. Malignant papillary lesions of the endometrium. Gynecol Oncol 1987;27:294-304.
4. Demopoulos RI, Genega B, Vamvakas E, Carlson E, Mittal K. Papillary carcinoma of the endometrium: morphometric predictors of survival. Int J Gynecol Pathol 1996;15:110-8.
5. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathological features. Am J Surg Pathol 1992;16:600-10.
6. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983:15:10-7.
7. Hendrickson MR, Longacre TA, Kempson RL. Uterine papillary serous carcinoma revisited. Gynecol Oncol 1994:54:261-3.
8. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995;26:1260-7.
9. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, ki67, estrogen and progesterone receptor expression. Hum Pathol 1998:29:551-8.
10. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997:150:177-85.
11. Kohler MF, Berchuck A, Davidoff AM, et al. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992;52:1622-7.
12. Berchuck A, Boyd J. Molecular basis of endometrial carcinoma. Cancer 1995 ;76:2034-40.
13. Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA. p53 over-expression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol 1996;61:167-74.
14. Koukoulis GK, Patriarca C, Gould VE. Adhesion molecules and tumor metastasis. Hum Pathol 1998:29:889-91.
15. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer Suppl 1996;77:1605-13.